1,25(OH)2D3 induces chondrocyte autophagy and reduces the loss of proteoglycans in osteoarthritis through inhibiting the NF-κB pathway
- PMID: 39775461
- DOI: 10.1007/s10067-024-07281-z
1,25(OH)2D3 induces chondrocyte autophagy and reduces the loss of proteoglycans in osteoarthritis through inhibiting the NF-κB pathway
Abstract
Objective: Nuclear transcription factor-κB (NF-κB) activation is a pivotal event in the pathogenesis of osteoarthritis (OA). OA patients frequently exhibit vitamin D (VD) deficiency, which is commonly associated with NF-κB activation. Our study aimed to investigate whether VD could protect against OA by modulating NF-κB pathway and to explore the underlying mechanisms.
Methods: Proteins levels were assessed by western blot analysis, gene expression was quantified by quantitative real-time polymerase chain reaction (qRT‒PCR) in vivo and in vitro. The expression of phosphorylated-p65 (p-p65) in knee OA rats was detected by immunohistochemistry, and an NF-κB nuclear translocation assay was validated in chondrocytes. Immunoprecipitation was employed to detect the interaction between NF-κB and vitamin D receptor (VDR) in vivo and in vitro. Small interfering RNA (Si-NF-κB and Si-VDR) transfection was used to investigate the role of NF-κB and VDR signaling pathway in knee OA rats under VD influence. Cartilage changes were visualized of knee OA rats using hematoxylin and eosin as well as safranin-O/fast green of staining.
Results: Our findings indicated that VD alleviates OA by inhibiting NF-κB pathway, which in turn reduces chondrocyte apoptosis and extracellular matrix (ECM) degradation. Further analysis revealed that VD primarily stabilizes NF-κB through the interaction of VDR and NF-κB, modulating the AMPK/mTOR signaling pathway to enhance autophagy and delay the progression of OA.
Conclusion: This study highlights the protective role of VD in OA by stabilization of NF-κB, mainly through the interaction between VDR and NF-κB. This interaction regulates the AMPK/mTOR signaling pathway, promoting autophagy and suggesting a potential therapeutic strategy for OA management. Key Points • VD confers a protective effect on OA by primarily stabilizing NF-κB through the interaction between VDR and NF-κB, which in turn inhibits NF-κB phosphorylation and nuclear translocation. • In chondrocytes, VD helps shield against OA by blocking NF-κB's entry into the nucleus, subsequently regulating autophagy via the AMPK/mTOR signaling pathway.
Keywords: NF-κB; Osteoarthritis; Signaling pathway; Vitamin D; Vitamin D receptor.
© 2025. The Author(s), under exclusive licence to International League of Associations for Rheumatology (ILAR).
Conflict of interest statement
Compliance with ethical standards. Disclosures: None. Statement of ethics and consent: All procedures were approved by the Experimental Animal Ethics Committee of Anhui Medical University (Approval No: LLSC20211506). Consent for sample procurement was obtained from the donors, adhering strictly to the ethical guidelines of China and the principle of the Helsinki Declaration.
Similar articles
-
Nuclear receptor 4A1 inhibits chondrocyte inflammation and cartilage degeneration in osteoarthritis by inhibiting NF-κB signal pathway.Inflammopharmacology. 2025 Apr;33(4):1965-1971. doi: 10.1007/s10787-025-01646-9. Epub 2025 Feb 18. Inflammopharmacology. 2025. PMID: 39964671
-
Vitamin D plays a protective role in osteoarthritis by regulating AMPK/mTOR signalling pathway to activate chondrocyte autophagy.Clin Exp Rheumatol. 2024 Mar;42(3):736-745. doi: 10.55563/clinexprheumatol/chmuts. Epub 2023 Oct 19. Clin Exp Rheumatol. 2024. PMID: 37877411
-
Active vitamin D activates chondrocyte autophagy to reduce osteoarthritis via mediating the AMPK-mTOR signaling pathway.Biochem Cell Biol. 2020 Jun;98(3):434-442. doi: 10.1139/bcb-2019-0333. Epub 2019 Dec 9. Biochem Cell Biol. 2020. Retraction in: Biochem Cell Biol. 2025 Jan 1;103:1. doi: 10.1139/bcb-2025-0020. PMID: 31815524 Retracted.
-
Mechanism of action and new developments in the study of curcumin in the treatment of osteoarthritis: a narrative review.Inflammopharmacology. 2025 Mar;33(3):929-940. doi: 10.1007/s10787-025-01665-6. Epub 2025 Feb 26. Inflammopharmacology. 2025. PMID: 40009345 Review.
-
NF-kappaB signaling: multiple angles to target OA.Curr Drug Targets. 2010 May;11(5):599-613. doi: 10.2174/138945010791011938. Curr Drug Targets. 2010. PMID: 20199390 Free PMC article. Review.
Cited by
-
Vitamin D Alleviates Osteoarthritis Progression by Targeting Cartilage and Subchondral Bone via Myd88-TAK1-ERK Axis Suppression.Drug Des Devel Ther. 2025 Jul 8;19:5855-5870. doi: 10.2147/DDDT.S526064. eCollection 2025. Drug Des Devel Ther. 2025. PMID: 40657039 Free PMC article.
References
-
- Hunter DJB-ZS (2019) Osteoarthritis. Lancet 393(10182):1745–1759. https://doi.org/10.1016/S0140-6736(19)30417-9 - DOI - PubMed
-
- Adam MS, Zhuang H, Ren X, Zhang Y, Zhou P (2024) The metabolic characteristics and changes of chondrocytes in vivo and in vitro in osteoarthritis. Front Endocrinol 15:1393550. https://doi.org/10.3389/fendo.2024.1393550 - DOI
-
- Pettenuzzo S, Arduino A, Belluzzi E, Pozzuoli A, Fontanella CG, Ruggieri P, Salomoni V, Majorana C, Berardo A (2023) Biomechanics of chondrocytes and chondrons in healthy conditions and osteoarthritis: a review of the mechanical characterisations at the microscale. Biomedicines 11(7):1942. https://doi.org/10.3390/biomedicines11071942 - DOI - PubMed - PMC
-
- Jang S, Lee K, Ju JH (2021) Recent updates of diagnosis, pathophysiology, and treatment on osteoarthritis of the knee. Int J Mol Sci 22(5):2619. https://doi.org/10.3390/ijms22052619 - DOI - PubMed - PMC
-
- Deng Y, Lu J, Li W, Wu A, Zhang X, Tong W, Ho KK, Qin L, Song H, Mak KK (2018) Reciprocal inhibition of YAP/TAZ and NF-kappaB regulates osteoarthritic cartilage degradation. Nat Commun 9(1):4564. https://doi.org/10.1038/s41467-018-07022-2 - DOI - PubMed - PMC
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous